BiotechTube
Biolog

Biolog

Hayward, United States· Est.
biolog.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Biolog is a long-established player in microbial analysis, leveraging its proprietary phenotypic technology to identify and characterize microorganisms. The company serves a dual market of industrial bioprocessing and clinical diagnostics, offering systems that analyze microbial metabolic fingerprints. Its core value proposition is providing rapid, accurate, and comprehensive identification that supports research, quality control, and disease diagnosis. As a private company, it has maintained a focused business model on instrumentation, consumables, and database services.

Infectious Disease

Technology Platform

Phenotypic microbial identification and metabolic analysis using proprietary microplates (e.g., GEN III MicroPlates) and instruments (OmniLog, MicroStation) that generate metabolic fingerprints for organism identification and characterization.

Opportunities

The growing microbiome research field requires functional analysis of microbial strains, creating a significant adjacent market for Biolog's phenotypic profiling technology.
Additionally, the expansion of the bioeconomy and industrial biotechnology drives demand for tools to rapidly screen and characterize microbial metabolism for manufacturing processes.

Risk Factors

Competition from faster and increasingly cost-effective genomic (sequencing) and proteomic (MALDI-TOF) identification technologies poses a displacement risk.
As a private, midsize company, competing with large, integrated diagnostics corporations for market share in clinical labs is also a significant challenge.

Competitive Landscape

Biolog competes in microbial identification with large diagnostic companies like bioMérieux (VITEK) and Becton Dickinson (BD Phoenix), as well as mass spectrometry (MALDI-TOF) providers like Bruker. Its key differentiation is the provision of functional metabolic data, rather than just taxonomic identification, which secures its niche in industrial and research applications.

More companies in Diagnostics & Precision Medicine →More companies in United States →